Salivary, but not serum or urinary levels of progesterone are elevated after topical application of progesterone cream to pre-and postmenopausal women

被引:25
作者
O'Leary, P
Feddema, P
Chan, K
Taranto, M
Smith, M
Evans, S
机构
[1] Royal Perth Hosp, Dept Biochem, Perth, WA 6001, Australia
[2] King Edward Mem Hosp Women, Women & Infants Res Fdn, Perth, WA, Australia
[3] King Edward Mem Hosp Women, Dept Gynecol, Perth, WA, Australia
关键词
D O I
10.1046/j.1365-2265.2000.01130.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE The use of topically applied micronised ('natural') progesterone as a substitute for synthetic oestrogens and progestogen preparations is controversial. The aim of this study was to examine the changes in blood and salivary concentrations of progesterone following a single topical application of a progesterone cream. PATIENTS AND MEASUREMENTS We investigated six premenopausal women in the luteal phase and six postmenopausal women to determine the short-term changes in serum, urinary and salivary progesterone concentrations following a single 64 mg topical application of micronised progesterone. RESULTS Serum progesterone concentrations did not increase during the first 3 hours after application of progesterone cream, however, salivary values rose significantly in both premenopausal and postmenopausal women, consistent with the view that progesterone is absorbed and transported through the body. Salivary progesterone concentrations were significantly elevated above basal levels by 30-60 minutes and reached peak levels at 1-4 h, with mean levels approximately fivefold higher in premenopausal, than in menopausal women. CONCLUSIONS Salivary progesterone measurements confirm that topically applied progesterone is absorbed, despite the lack of change in serum progesterone concentrations. However, at the dose administered, serum progesterone levels do not reach those observed after oral or vaginally delivered progesterone preparations. Higher doses may be required to induce biological responses within the endometrium.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 32 条
[21]  
McWhinney BC, 1996, CLIN CHEM, V42, P979
[22]   INCIDENCE OF OVULATION IN YOUNG-WOMEN [J].
METCALF, MG ;
MACKENZIE, JA .
JOURNAL OF BIOSOCIAL SCIENCE, 1980, 12 (03) :345-352
[23]  
METCALF MG, 1984, J ENDOCRINOL, V100, P25
[24]  
MUNRO CJ, 1991, CLIN CHEM, V37, P838
[25]  
NACHTIGALL MJ, 1992, OBSTET GYNECOL, V80, P827
[26]   PLASMA LEVELS OF PROGESTERONE AFTER VAGINAL, RECTAL, OR INTRAMUSCULAR ADMINISTRATION OF PROGESTERONE [J].
NILLIUS, SJ ;
JOHANSSON, ED .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1971, 110 (04) :470-+
[27]   ENDOMETRIAL DISEASE AFTER TREATMENT WITH ESTROGENS AND PROGESTOGENS IN THE CLIMACTERIC [J].
PATERSON, MEL ;
WADEEVANS, T ;
STURDEE, DW ;
THOM, MH ;
STUDD, JWW .
BRITISH MEDICAL JOURNAL, 1980, 280 (6217) :822-824
[28]   PROGESTERONE AS A BONE-TROPHIC HORMONE [J].
PRIOR, JC .
ENDOCRINE REVIEWS, 1990, 11 (02) :386-398
[29]  
Samsioe G, 1993, Int J Fertil Menopausal Stud, V38 Suppl 1, P23
[30]  
STEVENSON JC, 1995, BRIT J CLIN PRACT, V49, P87